Peginterferon alfa-2a (PEGASYS) (PEGASYS) – Uses, Dosage & Brands in UAE

About Peginterferon alfa-2a (PEGASYS)

Class: | Antiviral agent, Interferon Use: | Treatment of chronic hepatitis C in combination with ribavirin; treatment of chronic hepatitis B; treatment of certain types of cancers (e.g., hairy cell leukemia, chronic myeloid leukemia, and malignant melanoma) Adult dose: | 135 mcg subcutaneously once weekly Pediatric dose: | Not established for children under 18 years; dosing in adolescents may vary based on specific indications and should be determined by a healthcare provider Side effect

Drug Class

Antiviral agent, Interferon

Uses & Indications

Treatment of chronic hepatitis C in combination with ribavirin; treatment of chronic hepatitis B; treatment of certain types of cancers (e.g., hairy cell leukemia, chronic myeloid leukemia, and malignant melanoma)

Storage Requirements

Store in the refrigerator (2°C to 8°C or 36°F to 46°F); do not freeze; protect from light; may be kept at room temperature for up to 30 days before use

Manufacturer & Packaging

Manufacturer: F. Hoffmann-La Roche Ltd., SWITZERLAND

Package Size

1 Pre-filled Syringe (0.5ml)

Price & Supplier

Price in UAE: AED 1065.00

Dosage Information

Adult Dose

135 mcg subcutaneously once weekly

Pediatric Dose

Not established for children under 18 years; dosing in adolescents may vary based on specific indications and should be determined by a healthcare provider

Side Effects

Flu-like symptoms (fever, chills, fatigue), headache, nausea, vomiting, diarrhea, depression, anxiety, injection site reactions, and changes in liver function tests

Contraindications & Precautions

Hypersensitivity to peginterferon alfa-2a or any component of the formulation; autoimmune hepatitis; decompensated liver disease; severe hepatic impairment; concurrent use with certain medications that may cause significant drug interactions

Important Warnings

Risk of serious neuropsychiatric disorders (including depression and suicidal ideation), autoimmune disorders, and severe infections; monitor for signs of liver dysfunction and hematologic abnormalities; not recommended for use in patients with a history of severe depression or other psychiatric disorders without careful consideration and monitoring

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

Peginterferon alfa-2a (PEGASYS) – Uses, Dosage, and Brands in UAE